Tenofovir (disoproxil or alafenamide)

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Tenofovir (disoproxil or alafenamide) and local guidelines before prescribing.

Nucleotide analogue antiviral

Mechanism

Nucleotide reverse transcriptase inhibitor.

Uses

HIV infection, chronic hepatitis B, HIV pre-exposure prophylaxis.

Dosing

Side effects

Renal tubular dysfunction, reduced bone density, nausea, hepatitis flare on stopping (hepatitis B).

Interactions

NSAIDs and nephrotoxic drugs; didanosine.

Contraindications and cautions

Renal impairment (disoproxil)

Monitoring

eGFR, phosphate, urine protein, HBV DNA

Pregnancy and breastfeeding

Used in pregnancy where indicated

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

Check eGFR, phosphate and urinalysis; do not stop abruptly in hepatitis B.

More from the textbook: uses, cautions and other points
Where it is discussed in the book